Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma.
Huanli Xu(Capital Medical University), Masatoshi Makuuchi, Yutaka Midorikawa(University of Tokyo Hospital), Wei Tang(National Center for Global Health and Medicine), Yasuji Seyama(Hakodate Central General Hospital), Noribim Kokudo, Qian Guo(Nantong University), Fengshan Wang, Yoshinori Inagaki(Yokohama University of Pharmacy), Yasuhiko Sugawara(Kumamoto University), Munehiro Nakata(Tokai University), Ruoyan Gai
PubMed
April 23, 2009
Cited by 32
Related Papers
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma
|Gastroenterology|2008|765
Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma
|Annals of Surgery|2005|641
Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma
|The Lancet|1990|419